Compare NRSN & REED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRSN | REED |
|---|---|---|
| Founded | 2017 | 1987 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 8.8M |
| IPO Year | 2021 | 2009 |
| Metric | NRSN | REED |
|---|---|---|
| Price | $1.44 | $0.97 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $91.75 | N/A |
| AVG Volume (30 Days) | 36.8K | ★ 2.7M |
| Earning Date | 09-25-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $34,065,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $27.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.25 | $0.33 |
| 52 Week High | $7.50 | $5.97 |
| Indicator | NRSN | REED |
|---|---|---|
| Relative Strength Index (RSI) | 31.32 | 67.45 |
| Support Level | $0.61 | $0.72 |
| Resistance Level | $7.50 | $1.04 |
| Average True Range (ATR) | 0.33 | 0.19 |
| MACD | -0.10 | 0.06 |
| Stochastic Oscillator | 24.85 | 89.40 |
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
Reed's Inc is a branded beverage company offering a portfolio of natural, premium, and functional beverages under the Reed's and Virgil's brands. The company's portfolio of handcrafted, all-natural beverages is sold in outlets nationwide, including the natural and specialty food channel, grocery stores, mass merchants, drug stores, convenience stores, club stores, and on-premise locations, including bars and restaurants. The company operates in a single reportable segment, which consists of manufacturing carbonated beverages under Reed's and Virgil's brand names.